Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
CD4-H82E3 | Human | Biotinylated Human CD34 Protein, His,Avitag™ (MALS verified) |
|
||
CD4-H52H9 | Human | Human CD34 Protein, His Tag |
|
The purity of Biotinylated Human CD34 Protein, His,Avitag (Cat. No. CD4-H82E3) is more than 90% and the molecular weight of this protein is around 55-75 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Anti-CD34 mab-sirolimus (OrbusNeich) | Approved | Orbusneich | Coronary Restenosis | Orbusneich | 2013-01-01 | Coronary Restenosis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
shRNA-Modified CD34 Cell Therapy | Phase 1 Clinical | Kanglin Biotech (Hangzhou) Co Ltd | HIV Infections | Details | |
Alpha-galactosidase A stem cell therapy (University Health Network/Ozmosis) | Phase 1 Clinical | University Health Network | Fabry Disease | Details | |
Retroviral ADA-transduced CD34+ cells (NHGRI/UCLA) | Phase 2 Clinical | Ucla Biomedical Library | Adenosine deaminase deficiency | Details | |
Autologous peripheral blood stem cell therapy (CellProthera) | Cellprothera | Details | |||
Alecmestencel-T (Apceth) | Apceth Gmbh & Co Kg | Details | |||
γ-globin gene therapy (CSL Behring) | CSL-200 | Csl Behring Llc | Details | ||
Stem cell therapeutics (ExCellThera) | ECT-002; ECT-003; ECT-005; UM171 + UM092; UM171 + UM390 | Phase 2 Clinical | Excellthera Inc | Hematologic Neoplasms; Multiple Myeloma; Leukemia, Myeloid, Acute | Details |
Lentiviral vector transduced CD34+ cells Therapy | Phase 2 Clinical | Great Ormond Street Hospital For Children Nhs Foundation Trust | Granulomatous Disease, Chronic | Details | |
CLBS-12 | CLBS-12 | Phase 2 Clinical | Caladrius Biosciences Inc | Atherosclerosis; Thromboangiitis Obliterans; Ischemia | Details |
GSK-2696277 | GSK-2696277; OTL-300 | Phase 2 Clinical | Glaxosmithkline Plc, Ospedale San Raffaele, Fondazione Telethon | beta-Thalassemia | Details |
Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene (Orchard) | OTL-201 | Phase 2 Clinical | The University Of Manchester | Mucopolysaccharidosis III | Details |
CD34+ bone marrow stem cells (University of California) | Phase 2 Clinical | The University Of California Davis | Retinitis Pigmentosa; Diabetic Retinopathy; Macular Degeneration; Retinal Vein Occlusion | Details | |
Autologous CD34+-enriched hematopoietic stem and progenitor cells (Genenta Science) | Phase 2 Clinical | Genenta Science Srl | Glioblastoma; Multiple Myeloma | Details | |
Cord blood stem cells(Tatcitus Therapeutics/Mount Sinai Health System) | HSC-100 | Phase 1 Clinical | Icahn School Of Medicine At Mount Sinai, Tatcitus Therapeutics | Leukemia; Hematologic Neoplasms; Hodgkin Disease; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Non-Hodgkin | Details |
This web search service is supported by Google Inc.